X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (371) 371
Book Chapter (42) 42
Publication (37) 37
Conference Proceeding (28) 28
Book / eBook (4) 4
Book Review (2) 2
Dissertation (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (142) 142
index medicus (128) 128
analysis (68) 68
cost-benefit analysis (67) 67
female (62) 62
male (62) 62
incremental cost-effectiveness ratio (48) 48
studies (47) 47
cost-effectiveness (39) 39
economics (39) 39
incremental net benefit (34) 34
management (34) 34
middle aged (33) 33
quality-adjusted life years (33) 33
cost analysis (30) 30
aged (29) 29
cost-effectiveness analysis (29) 29
health care sciences & services (29) 29
incremental prognostic value (28) 28
methods (27) 27
adult (26) 26
incremental value (26) 26
cardiac & cardiovascular systems (25) 25
algorithms (24) 24
models (24) 24
risk factors (24) 24
research (23) 23
incremental validity (21) 21
medicine, research & experimental (21) 21
decision making (20) 20
health policy & services (19) 19
incremental-present-worth (19) 19
kapitalwert (19) 19
performance (19) 19
cardiology (18) 18
medicine & public health (18) 18
mortality (18) 18
public, environmental & occupational health (18) 18
cost benefit analysis (17) 17
health (17) 17
patients (17) 17
validation (17) 17
article (16) 16
diagnosis (16) 16
economic aspects (16) 16
energy & fuels (16) 16
medical informatics (16) 16
public health (16) 16
radiology, nuclear medicine & medical imaging (16) 16
risk assessment (16) 16
confidence-intervals (15) 15
coronary-artery-disease (15) 15
health care costs (15) 15
prognosis (15) 15
quality of life (15) 15
risk (15) 15
risk assessment - methods (15) 15
care and treatment (14) 14
clinical trials (14) 14
computer science (14) 14
disease (14) 14
internal medicine (14) 14
medical care, cost of (14) 14
statistics & probability (14) 14
united-states (14) 14
health aspects (13) 13
health economics (13) 13
incremental cost (13) 13
incremental cost effectiveness ratio (13) 13
infectious diseases (13) 13
models, economic (13) 13
models, statistical (13) 13
optimization (13) 13
personality (13) 13
research article (13) 13
treatment outcome (13) 13
united states (13) 13
usage (13) 13
aged, 80 and over (12) 12
business (12) 12
cancer (12) 12
computer simulation (12) 12
confidence intervals (12) 12
epidemiology (12) 12
immunology (12) 12
incremental cost‐effectiveness ratio (12) 12
quality-of-life (12) 12
sensitivity and specificity (12) 12
artificial intelligence (11) 11
coronary heart disease (11) 11
economic evaluation (11) 11
health policy (11) 11
incremental innovation (11) 11
innovations (11) 11
mathematical models (11) 11
model (11) 11
prediction (11) 11
predictive value of tests (11) 11
prospective studies (11) 11
psychology, applied (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Indian Journal of Fisheries, ISSN 0970-6011, 2017, Volume 64, Issue 3, pp. 85 - 92
Seasonal fishing ban (SFB) is followed along the Indian coast for the past 15 to 25 years for sustaining marine fishery resources. However, the effect of the... 
Seasonal fishing ban | Economic valuation | Transaction cost | Sustainability | Social benefit | Incremental biomass | FISHERIES
Journal Article
The European Journal of Health Economics, ISSN 1618-7598, 6/2012, Volume 13, Issue 3, pp. 237 - 250
The incremental net benefit (INB) and the related acceptability curves for public health programs provide valuable tools for decision making. We proposed to... 
Health screening | Health care costs | Immunology | Cost estimates | Screening tests | Colonoscopy | Colorectal cancer | Adenoma | Occult blood testing | Cancer screening | Economic Policy | Incremental net benefit | Statistics for Life Sciences, Medicine, Health Sciences | Fecal occult blood test | Computed tomography colonoscopy | Health Informatics | Public Health/Gesundheitswesen | I19 | Medicine & Public Health | Statistics for Business/Economics/Mathematical Finance/Insurance | Public Finance & Economics | Cost-effectiveness | COLONOSCOPY | CT COLONOGRAPHY | RISK | HEALTH POLICY & SERVICES | ECONOMICS | PROGRAM | ADENOMAS | Decision Making | Early Detection of Cancer - economics | Markov Chains | Prevalence | Health Status Indicators | Tomography, X-Ray Computed - economics | Humans | Middle Aged | Probability | Male | Models, Economic | Public Health - economics | Colorectal Neoplasms - diagnosis | Colorectal Neoplasms - economics | Patient Satisfaction | Risk Assessment - economics | Cost-Benefit Analysis | Aged, 80 and over | Female | Aged | Occult Blood | France | Health Policy | Case studies | Medical examination | Analysis | Markov processes | Universities and colleges | Diagnosis | Medical screening | Public health | Blood | Cancer | Studies | Benefit cost analysis | Blood tests | Economics and Finance | Humanities and Social Sciences
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 31, pp. 3823 - 3833
Abstract Recognizing that infectious agents readily cross international borders, the International Health Regulations Emergency Committee issues Temporary... 
Allergy and Immunology | Polio eradication | Outbreaks | Health economics | International Health Regulations | Traveler vaccination | MEDICINE, RESEARCH & EXPERIMENTAL | WILD POLIOVIRUS | IMMUNOLOGY | OUTBREAK | Travel-Related Illness | Poliomyelitis - prevention & control | Global Health | Medication Reconciliation - economics | Cost-Benefit Analysis | Humans | Travelers | Models | Analysis | Vaccination | Public health | Regulations | Economic analysis | Costs | Importation | Propagation | Accounting | Gross National Income--GNI | Vaccines | Cost benefit analysis | Exporting | Investments | Poliomyelitis | Borders | Cost engineering | Economic models | International regulations | Computer simulation | Emergencies | Data processing | Disease control | Estimates | Infectious diseases | year 2015 United States dollars | cMYP, comprehensive multi-year plan | POE, point of entry | cVDPV, circulating vaccine-derived poliovirus (of serotype 2) | IPV, inactivated poliovirus vaccine | OPV, oral poliovirus vaccine | oSIA, outbreak response supplemental immunization activity | HF, health facility | INB, incremental net benefit | pSIA, planned preventive supplemental immunization activity | TR, temporary recommendations | WPV1, serotype 1 wild poliovirus | IHREC, International Health Regulations Emergency Committee | WHO, World Health Organization
Journal Article
Health Services and Outcomes Research Methodology, ISSN 1387-3741, 6/2010, Volume 10, Issue 1, pp. 86 - 99
Journal Article
OPEN FORUM INFECTIOUS DISEASES, ISSN 2328-8957, 04/2019, Volume 6, Issue 4, p. ofz117
Background. Rotavirus causes morbidity and mortality in children particularly in low-income countries (LICs) and lower-middle-income countries (LMICs). This... 
INFECTIOUS DISEASES | ESTIMATED IMPACT | meta-analysis | MICROBIOLOGY | IMMUNOLOGY | cost-effectiveness analysis | NET-BENEFIT | incremental net benefit | IMMUNIZATION | DIARRHEAL DISEASE | ECONOMIC-EVALUATION | rotavirus | UNCERTAINTY | PROGRAM | INDIA
Journal Article
16.